Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NVDL vs GSK✓SelectedUSD · GSKNVDL vs GSK performance historyLatest closeAs of-27.51%11/20
Stock and ETF performance explorer

NVDL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-68.4%
GSK return
-3.6%
Excess return
-64.8%
Maximum drawdown
-69.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-27.5%-0.1%-27.4%-27.6%
7D-42.1%-5.3%-36.7%-44.6%
30D-69.9%-3.7%-66.2%-70.6%
All-68.4%-3.6%-64.8%-69.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1mo analysis · Full analysis span regression · Available span rolling